Novacyt Named in Deloitte Technology Fast 500

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 500 for Europe, Middle East and Africa. Download press release

Visit Page

Novacyt Named in Deloitte Technology Fast 50

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 50 in France. Download press release

Visit Page

Novacyt appoints Anthony Dyer as Finance Director

Novacyt (Mmemo: ALNOV – FR0010397232) announces that Anthony Dyer will become Finance Director. Download press release

Visit Page

Novacyt strengthens board

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics is pleased to announce the addition of new members to its Board as the Company prepares for the next stages of growth. Download press release

Visit Page

Novacyt appoints new Group Commercial Director

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has appointed Manuela Gazzard as Commercial Director. Download press release

Visit Page